FLIXOTIDE ACCUHALER - Medsafe
4 Rarely, Flixotide Accuhaler can cause soreness in the oesophagus. Very rarely, Flixotide Accuhaler can cause swelling of the throat and face.
Download FLIXOTIDE ACCUHALER - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
182x.-USO DE CÁMARAS DE INHALACIÓN
www.1aria.comDocumentos www.1aria.com Uso de cámaras de inhalación para inhaladores en cartucho presurizado Cámaras financiadas. Cámaras para niños menores de 4 años
Chronic Illness Benefit medicine list (formulary) 2018
www.lahealth.co.zaChronic Illness Benefit medicine list (formulary) 2018 Who we are LA Health Medical Scheme (referred to as 'the Scheme’), registration number 1145, is a non-profit
Flixotide Inhaler NZ CMI 003 approved - Medsafe
www.medsafe.govt.nz1 FLIXOTIDE® INHALER Fluticasone propionate (CFC-Free) Inhaler 50, 125 or 250μg per actuation Consumer Medicine Information Please read this leaflet carefully before you start using Flixotide (CFC-free) Inhaler.
Sizwe Medical Fund: CDL Formulary - All Options
www.sizwe.co.zaSizwe Medical Fund: CDL Formulary - All Options This formulary is a summary of treatment covered on the Chronic Disease List (CDL) Formulary.
LASTEN SPIROMETRIATUTKIMUS - hoito-ohjeet.fi
hoito-ohjeet.fiLASTEN SPIROMETRIATUTKIMUS Spirometriatutkimuksessa mitataan keuhkojen toimintaa. Spirometrialla tarkoitetaan keuhkojen …